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ABSTRACT
Pemphigus vulgaris produces multiple and intractable erosions of the oral mucosa in the head 
and neck region. We describe a case of pemphigus vulgaris that showed erosions in the 
hypopharynx and stenosis of the esophageal orifice from an osteoporosis drug. A 73-year-old 
woman was admitted with oral intake difficulty and erosions in the hypopharynx. During the 
first admission, we could not make a definite diagnosis by biopsy or blood examination. The 
condition of the mucosa worsened subsequently; an esophagram showed marked stenosis of the 
esophageal orifice. As a possible factor exacerbating the stenosis, an osteoporosis drug was 
considered. The stenosis was improved by balloon expansion. One year after the first medical 
examination, we finally made a definite diagnosis of pemphigus vulgaris from the results of a 
blood examination in which anti-desmoglein 3 turned positive when the hypopharyngeal erosions 
and stenosis of the esophageal orifice became worse. Systemic treatment with a steroid was 
effective for the control of pemphigus vulgaris; restenosis of the esophageal orifice was recognized 
twice during a state of remission, and careful follow-up will be necessary in the future.
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Pemphigus vulgaris (PV) is an autoimmune dis-
ease that mainly presents with blisters on the skin 
or mucosal epithelium. In head and neck lesions, 
PV is known to form multifocal refractory erosions 
in the oral cavity. Cell-cell adhesion is inhibited by 
epidermal autoantibodies against cell surface and 
acantholytic bullar antigens.
Based on clinical, pathological, and serological 
findings, pemphigus is classified into three major 
types: PV, pemphigus foliaceus (PF), and others 1,2). 
The PV antigen is desmoglein (Dsg) 3 and the PF 
antigen is Dsg1. These are used for diagnosis, pem-
phigus staging, and an evaluation of the condition 
by measuring antibody titers of the IgG type. PV 
can be further classified as mucosa-dominant or 
mucocutaneous PV. 
The initial symptoms of PV are generally painful 
refractory erosions and ulcers, which in severe 
cases can cause an inability to ingest food. In ap-
proximately 50% of patients with PV, the lesions 
are not only located on the oral mucosa but also 
involve the skin with flaccid bullae and erosions2).
We report the case of a patient with PV who pre-
sented at our hospital with a chief complaint of oral 
intake difficulty due to hypopharyngeal erosion 
and stenosis of the esophageal orifice. Making a 
definite diagnosis and treating this case proved 
challenging.
CASE REPORT
A 73-year-old woman became aware of a gradually 
worsening feeling of dysphagia and her weight de-
creased by 10 kg over 3 months; hence, she visited 
a nearby hospital. She underwent esophagogastro-
duodenoscopy (EGD), which detected a hemorrhagic 
lesion in the esophageal orifice. Enhanced computed 
tomography (CT) and magnetic resonance imaging 
(MRI) revealed mucosal thickening and enhance-
ment in the hypopharynx and esophageal orifice; 
as a result, hypopharyngeal cancer was suspected. 
She was referred to our hospital for a comprehensive 
examination.
Her medical history included oral lichen planus, 
mild liver dysfunction, and osteoporosis.
The buccal mucosa showed mild erosion. A hypo-
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definite diagnosis. 
The erosions in the oral cavity and hypopharynx 
remained. However, she was discharged from the 
hospital because she could eat enough food to main-
tain her weight.
She was followed up once a month in the outpa-
tient department with intractable recurrent ulcers. 
However, her dysphagia gradually worsened. One 
year after the first admission, she was hospitalized 
again because of an inability to ingest food and 
marked stenosis, which was found in the esophageal 
orifice by esophagography. The thoracic and abdom-
inal esophageal mucosae were intact (Fig. 2a, 2b).
We checked the medication she brought to the 
second admission, and found that sodium risedro-
nate hydrate had been prescribed as a treatment for 
osteoporosis by her family physician. This medica-
tion is contraindicated in patients with esophageal 
stenosis; hence, we advised her to stop taking it 
immediately. For her nutrition, we intended to 
place a nasogastric tube in her stomach. However, 
we could not do so because of the stenosis of the 
esophageal orifice; therefore, we initiated intrave-
nous hyperalimentation.
When we again performed a biopsy and observa-
pharyngeal fiberscope revealed extensive mucosal 
erosions in both arytenoid cartilages, the piriform 
fossa, and posterior wall with a left-sided predomi-
nance in the hypopharynx. No elevated lesion was 
found, and the mobility of the vocal cords was nor-
mal (Fig. 1a).
Cervical enhanced CT and MRI revealed mucosal 
swelling in both arytenoid cartilages, the piriform 
fossa, and posterior wall with a left-sided predomi-
nance in the hypopharynx. No elevated lesion was 
found (Fig. 1b, 1c).
We performed a biopsy under general anesthesia 
and obtained tissues from the hypopharyngeal pos-
terior wall and both sidewalls; however, the patholo-
gy results only revealed a fibrin lump and chronic 
inflammation. Skin lesions were not observed over 
the whole body, the Nikolsky phenomenon was neg-
ative, and increases in Dsg1 and 3 antibodies were 
also not found in the blood examination from the 
first admission.
We referred the patient to the departments of 
collagenosis, dermatology, blood internal medicine, 
and gastroenterological internal medicine to exclude 
the presence of various diseases that could result in 
intraoral erosions. However, we could not make a 
a b c
a b c d
Fig.1: A hypopharyngeal fiberscope (a) reveals mucosal erosion in both aryte-
noids, the piriform fossa, and posterior wall with left-sided dominance in the hy-
popharynx. Enhanced CT (b) and MRI (c) reveal mucosal thickening and an en-
hancement effect (arrow) at the site.
Fig.2: Esophagography before treatment (a: frontal position, b: left anterior 
oblique position) revealed marked stenosis (arrow) in the esophageal orifice. The 
stenosis was improved (arrow) after balloon expansion (c: frontal position, d: left 
anterior oblique position).
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patient, we performed a graded expansion according 
to a plan for 5 min at 300 kPa (Fig. 3).
The second balloon expansion was performed 2 
weeks after the initial expansion. Her symptoms 
improved dramatically postoperatively, and the re-
lease of stenosis was confirmed by esophagography 
1 week after the second expansion (Fig. 2c, 2d). 
On the day after the second expansion, she was able 
to eat and was discharged from the hospital.
When erosions in the oral cavity and hypophar-
ynx rapidly worsened 8 months after the second 
discharge, we again performed a blood examination, 
and immunostaining was positive for the anti-Dsg3 
antibody, while those for anti-Dsg1 antibody re-
mained negative. Hence, we diagnosed her with 
mucosa-dominant PV. Systemic treatment with 
prednisolone from 10 mg/day was started in der-
matology immediately, and the erosions improved 
significantly (Fig. 4a).
The stenosis of the esophageal orifice worsened 
with an exacerbation of PV and dysphagia appeared 
9 months and 4 years after the start of steroid ther-
apy. She was re-hospitalized on both instances. We 
performed balloon expansions immediately and the 
stenosis improved. With her condition in remission, 
enhancement of the hypopharyngeal mucosa on 
CT was only seen a little in the left piriform fossa 
(Fig. 4b).
Stenosis has not recurred in 6 years and her 
clinical course is favorable.
DISCUSSION
Autoimmune blistering disease is known to result 
in an esophageal mucosal disorder by a mechanism 
similar to that of a disorder of the skin, but esopha-
geal stenosis is not usually found in mucosa-domi-
nant PV and we could not find case reports in which 
esophageal stenosis was caused by PV. However, 
esophageal stenosis is found in pemphigoid and 
there are some case reports of pemphigoid that re-
sulted in esophageal stenosis5,6). It is assumed that 
the difference between the two is where the site of 
tion under general anesthesia, erosions and a 
white coating were observed on all circumferences 
and the hypopharyngeal space had narrowed. At 
the narrowest region, the diameter of the esopha-
geal orifice was only 4 mm wide and observation 
of the esophagus was not possible.
We obtained tissue from multiple sites including 
the posterior wall, sidewall, and some narrow seg-
ments in the hypopharynx and esophageal orifice. 
However, pathological analysis revealed that the 
quantity of the biopsy specimen was limited, malig-
nancy was not found in any of the epithelia, immu-
nostaining was negative for both anti-Dsg 1 and 3 
antibodies, and increases in anti-Dsg1 and anti-Dsg3 
antibody titers were not observed in the blood exami-
nation.
Consequently, we determined that the intractable 
recurrent ulcers were exacerbated by the osteopo-
rosis drug and that treatment was necessary for 
benign hypopharynx/esophageal stenosis; thus, we 
performed balloon expansion. Since extensive ex-
pansion was thought to increase the risk of hypo-
pharyngeal and esophageal orifice rupture in the 
ba
Fig.3: A view of the balloon expansion technique. We 
performed it twice over 5 minutes at 300kPa and the 
second expansion was easier than the first one.
Fig.4: The hypopharyngeal fiberscope (a) only reveals slight scarring of the 
hypopharyngeal mucosa and enhanced CT (b) reveals slight mucosal thickening 
after steroid treatment.
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tively, the patient was able to ingest food orally, 
and the expansion technique was thought to be ef-
fective for esophageal stenosis correlated with PV. 
When her PV was in a state of remission, reste-
nosis was found only twice in 10 years. We will 
perform a balloon expansion again if restenosis is 
found in the future with an exacerbation of PV.
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the target antigen is localized. 
Since PV is a disorder of a shallow layer of the 
mucous membrane, it only presents with esophageal 
erosions. However, as pemphigoid is a disorder in 
a deeper layer of the mucous membrane than PV9), 
it presents as a serious disorder with symptoms 
such as exfoliation of all layers of the mucous mem-
brane and esophageal stenosis caused by scarring.
A bisphosphonate preparation is widely used as 
a therapeutic drug for osteoporosis and upper gas-
trointestinal tract disorders such as esophagitis, 
esophageal perforation, esophageal stenosis, esoph-
ageal ulcer, etc., have been reported as serious side 
effects thus far10). These side effects result from 
the direct membrane-irritating effects of the prep-
aration, sustained contact, and gastric reflux of 
the melted drug8). Hence, patients are required to 
consume this medication between meals with 
enough water (approximately 180 ml) and remain 
in a seated position for at least 30 min after use4).
In the present case, PV caused the esophageal 
erosion; the osteoporosis drug came into direct 
contact with the area of the esophageal erosion, and 
inflammation occurred in a deep layer of the mu-
cous membrane. Thus, we assume that esophageal 
stenosis as in pemphigoid occurred in this patient.
We could not make a definite diagnosis of PV at 
first by biopsy or blood examination because we 
considered that there are some cases in which anti-
Dsg3 antibody cannot be detected meaningfully by 
staining the biopsy specimen, and an increase in 
anti-Dsg3 antibody is not found in the blood exam-
ination when disease progression is weak. 
 Kamiya et al reported that they could detect 
the anti-Dsg3 antibody by using serum condensed 
more than 10 times against PV in patients who 
could not be diagnosed using indirect immunofluo-
rescence or enzyme-linked immunosorbent assay7). 
We assume this method would have been efficient 
for diagnosing this patient with PV.
In pemphigus treatment, a steroid is recommend-
ed by the Committee for Guidelines for the Man-
agement of Pemphigus Disease2). In this case, the 
mucosal lesion showed dramatic improvement after 
steroid administration; however, esophageal steno-
sis recurred during an exacerbation of PV. Since 
the antibody titers correlate with the activity of 
pemphigus3), adjusting steroid doses by measuring 
antibody titers is required for adequate control.
When we use osteoporosis drugs in patients 
with PV, it is necessary to confirm the absence of 
esophageal and hypopharyngeal mucosal disorders.
Moreover, we performed the balloon expansion 
technique for the esophageal stenosis. Postopera-
